AORT · XBRL financial data

Artivion financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (AORT's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	88	94*	97	98	96	97*	99	113	113	116*	116	126
Cost of goods and services sold	32	33*	34	35	35	36*	35	40	39	43*	41	45
Gross profit	56	61*	63	63	61	62*	64	73	74	73*	75	81
Research and development	6	8*	7	7	7	7*	7	7	8	9*	9	9
Selling, general and administrative	51	50*	31	49	50	51*	55	58	57	57*	61	80
Total operating expenses	58	58*	38	57	57	59*	61	65	65	66*	70	89
Operating income (loss)	(1)	3*	25	7	4	3*	2	8	13	11*	6	(8)
Interest income	0	0*	0	0	0	0*	0	0	0	0*	0	0
Interest expense	7	6*	8	8	8	10*	8	7	6	6*	5	7
Other income (expense)	(2)	2*	(1)	(1)	2	(10)*	3	5	0	1*	(0)	4
Income tax expense (benefit)	0	3*	5	(0)	1	(0)*	(2)	2	1	4*	(1)	2
Net income (loss)	(10)	(4)*	8	(2)	(2)	(16)*	(1)	1	7	2*	1	(14)
Earnings per share, basic USD per share	(0.24)	(0.10)*	0.18	(0.05)	(0.05)	(0.39)*	(0.01)	0.03	0.14	0.05*	0.03	(0.28)
Earnings per share, diluted USD per share	(0.24)	(0.10)*	0.18	(0.05)	(0.05)	—	(0.01)	0.03	0.13	0.05*	0.03	(0.28)
Weighted average shares, basic millions of shares	41	41*	41	42	42	42*	42	44	47	48*	48	49
Weighted average shares, diluted millions of shares	41	41*	48	42	42	35*	42	45	49	52*	50	49

Fiscal quarters (AORT's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	53	59	51	55	56	53	38	53	73	65	56	77
Accounts receivable	64	72	74	74	76	79	88	91	88	90	92	98
Inventory	79	82	82	81	84	80	82	87	91	92	98	103
Prepaid and other current assets	17	16	17	20	19	19	20	25	22	43	45	27
Total current assets	267	281	277	285	288	290	287	319	337	358	358	371
Property and equipment, net	37	38	38	37	38	36	38	40	41	65	68	74
Right-of-use asset	43	44	42	42	41	40	39	40	39	35	35	37
Goodwill	243	247	245	244	249	241	245	254	254	254	252	350
Total assets	775	792	784	790	803	789	791	838	858	885	883	1,072
Accounts payable	11	13	10	12	11	18	12	19	16	16	18	21
Accrued liabilities	10	13	16	16	16	12	12	11	12	16	17	16
Current portion of long-term debt	2	1	0	0	100	0	0	0	0	0	0	0
Total current liabilities	55	58	46	51	153	67	52	67	86	102	93	107
Long-term debt	306	306	313	313	214	314	315	216	215	215	215	363
Lease liability, non-current	43	44	43	42	41	40	39	39	38	34	34	36
Total liabilities	503	511	489	494	498	513	497	418	419	437	433	626
Accumulated deficit	(44)	(48)	(40)	(42)	(45)	(61)	(62)	(60)	(54)	(51)	(50)	(64)
Total stockholders' equity	272	282	295	295	305	276	294	420	439	448	450	446
Total liabilities and equity	775	792	784	790	803	789	791	838	858	885	883	1,072
Common shares outstanding (cover page) millions of shares	41	41	42	42	42	42	43	47	47	48	49	49

Fiscal quarters (AORT's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(10)	(4)*	8	(2)	(2)	(16)*	(1)	1	7	2*	1	(14)
Stock-based compensation	3*	4*	3	4*	4*	3*	8	6*	6*	4*	8	8*
Depreciation and amortization	6*	6*	6	6*	6*	6*	5	6*	6*	6*	6	7*
Net cash from operating activities	7*	11*	(5)	6*	11*	10*	(17)	15*	22*	20*	1	(1)*
Purchases of property and equipment	1*	2*	4	3*	4*	1*	4	3*	5*	28*	8	11*
Net cash from investing activities	(2)*	(3)*	(4)	(3)*	(11)*	(11)*	(4)	(3)*	(5)*	(31)*	(11)	(129)*
Proceeds from issuing common stock	1*	0*	4	0*	2*	0*	4	0*	5*	3*	1	1*
Proceeds from long-term debt	0*	0*	30	0*	0*	154*	0	0*	0*	0*	—	—
Repayments of long-term debt	1*	1*	212	0*	0*	0*	0	0*	0*	0*	0	0*
Net cash from financing activities	(1)*	(2)*	1	(0)*	1*	0*	4	3*	2*	2*	0	152*
Net change in cash	5*	5*	(8)	4*	1*	(3)*	(16)	16*	20*	(9)*	(9)	22*

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Artivion	77	126	(1.3)*	48.8M	61.1 quarters	Q2 FY26 10-QJun 30, 2026
Alphatec Holdings	80	221	19*	155.1M	—	Q3 FY26 10-QSep 30, 2026
Tandem Diabetes Care	63	255	(35)*	69.6M	13.2 quarters	Q2 FY26 10-QJun 30, 2026
AtriCure	168	154	22*	50.9M	—	Q2 FY26 10-QJun 30, 2026
CONMED	48	336	49*	29.8M	—	Q3 FY26 10-QSep 30, 2026
Lemaitre Vascular	27	not reported	16*	22.9M	—	Q2 FY26 10-QJun 30, 2026
Ufp Technologies	9	174	16*	7.7M	—	Q2 FY26 10-QJun 30, 2026
Enovis	13	583	75*	57.7M	—	Q2 FY26 10-QJul 3, 2026
NovoCure	97	193	23	116.9M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.